FilingReader Intelligence
HEC ChangJiang Pharmaceutical completes delisting for merger
August 4, 2025 at 10:19 PM UTC•By FilingReader AI
Yichang HEC ChangJiang Pharmaceutical Co delisted its H shares from the Hong Kong Stock Exchange on August 5 as part of a merger with Sunshine Lake Pharma Co.
The deal involves a share exchange ratio of 1 H share for 0.263614 shares in the acquiring company.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
HKEX:1558•Hong Kong Exchange
News Alerts
Get instant email alerts when Yichang HEC ChangJiang Pharmaceutical publishes news
Free account required • Unsubscribe anytime